Exhibiting at VIV Asia 2025

Pharmgate Animal Health, headquartered in Wilmington, North Carolina, USA, is a leading provider of animal health solutions focused on antibiotics, vaccines, medicated feed additives, and water-soluble medications for swine and poultry industries. Established in 2008 as a joint venture between Jinhe Biotechnology and Pharmgate LLC, the company integrates global innovation with U.S.-based manufacturing to deliver regulatory-compliant, high-efficacy solutions for intensive livestock production.

Core Business

Pharmgate's core business revolves around the development, manufacturing, and distribution of pharmaceutical and biological products to prevent and treat economically significant diseases in poultry and swine. The company operates under stringent FDA, USDA, and cGMP compliance, and focuses on antimicrobial stewardship, responsible medication use, and improved production outcomes.

Its hybrid approach to health management combines in-feed, in-water, and injectable treatment programs with a growing biologics portfolio for disease prevention.

Product and Service Offerings

Pharmgate’s product portfolio is divided into four primary categories:

• Antibiotics and Antibacterials:

  • Aivlosin® (Tylvalosin): Effective against Mycoplasma and Lawsonia in swine and poultry.
  • Pennchlor® (Chlortetracycline): Medicated feed additive for respiratory and enteric disease control.
  • Deracin® (Chlortetracycline): Broad-spectrum antibiotic with FDA approvals for feed and water use.

• Biologicals and Vaccines:

  • MycoGard®: Mycoplasma hyopneumoniae vaccine for swine.
  • CircoGard®: PCV2 vaccine designed to reduce viral load and improve growth performance.
  • PRRSGard® (in development): A targeted vaccine solution for PRRSv management.

• Medicated Feed Additives:

  • Pennitracin® MD: Bacitracin Methylene Disalicylate for growth promotion and enteric disease control.
  • ZoaShield® (Zoalene): Anticoccidial solution for broilers.

• Water-Soluble Medications:

  • Aivlosin® WSG: Tylvalosin tartrate for respiratory and enteric infections.
  • Deracin® Soluble: For water administration during acute outbreaks.

All products are supported by extensive field data, veterinary education, and regulatory guidance.

Specialization and Unique Selling Proposition

Pharmgate specializes in comprehensive health programs tailored to the realities of modern livestock production, with unique capabilities in:

• Dual Manufacturing Base: U.S. cGMP-certified facility in Omaha, Nebraska, and biotechnology collaboration with Jinhe Biotech in China.
• Disease-Specific Programs: Integrated antibiotic and vaccine solutions targeting PRRS, PCV2, Mycoplasma, Lawsonia, and more.
• Regulatory Leadership: Holds multiple FDA and USDA approvals, including pioneer and generic registrations.
• Antimicrobial Stewardship: Products designed to comply with VFD guidelines and international reduction policies.

This scientific and regulatory balance enables Pharmgate to deliver safe, effective, and scalable health solutions.

Financial Performance

While privately held, industry reports and market research estimate:

• Estimated Annual Revenue: USD 60–80 million
• Revenue Split:
  • 55% Medicated Feed Additives
  • 30% Biologicals & Vaccines
  • 15% Water-Soluble and Injectables
• Global Market Reach: Products available in North America, Latin America, and select Asian and European markets

Revenue growth is supported by new product registrations and vaccine portfolio expansion.

Shipment Records

Based on data from import/export intelligence platforms:

• Annual Shipments: 1,200–1,500 consignments globally
• Primary Export Markets: Canada, Mexico, Brazil, Philippines, Vietnam
• Top Exported Products: Aivlosin®, MycoGard®, CircoGard®
• Logistics Capabilities: U.S. national warehouse network and global distributors

The company offers regulatory support and pharmacovigilance documentation for all export shipments.

Target Market

Pharmgate primarily serves:

• Commercial swine and poultry integrators
• Veterinarians and production consultants
• Feed manufacturers and medicated feed mills
• Distributors and pharmaceutical wholesalers
• Governmental animal health programs

Its customer base spans intensive production systems and mid-sized operations seeking disease control and production efficiency.

Capabilities

• U.S. Manufacturing Plant: Located in Omaha, NE – FDA-inspected, GMP-compliant, multi-product facility
• R&D: Applied research on disease prevalence, resistance patterns, and vaccine efficacy
• Regulatory Affairs: Dedicated team handling U.S. FDA, USDA, and international dossiers
• Veterinary Support: Technical service veterinarians and swine/poultry health consultants
• Product Innovation: Pipeline includes PRRSv vaccine, probiotic-enzyme blends, and next-gen delivery formats

Pharmgate combines technical agility with industrial-scale manufacturing to serve global animal health needs.

Certifications and Compliance

Pharmgate adheres to strict regulatory and quality standards:

• U.S. FDA cGMP Compliance (21 CFR 514)
• USDA Center for Veterinary Biologics License
• VFD-Compliant Product Line
• Licensed in Canada (VDD), Brazil (MAPA), and select APAC countries
• Participates in pharmacovigilance and AMR monitoring programs

All batches undergo in-process and final product QA testing prior to release.

Customer Testimonials

“Pharmgate's Aivlosin® is a go-to solution for Mycoplasma control in our multi-site broiler systems. It works quickly and with low residue concerns.”
— Daniel W., Poultry Veterinarian, USA

“We’ve used CircoGard® in our integrated pig operations and seen improved ADG and uniformity. Their team helped optimize our timing and co-administration.”
— Juan L., Swine Production Manager, Mexico

Major Achievements

• Aivlosin® Approval: Among the first tylvalosin-based antibiotics approved for feed, water, and injectable use in North America
• Vaccine Expansion: USDA licensure of MycoGard® and CircoGard® for swine
• Regulatory Excellence: Multiple FDA pioneer and ANADA registrations
• Research Partnerships: Ongoing collaboration with U.S. veterinary universities and international CROs
• Growth Strategy: Expanded Latin American footprint with local partnerships and regulatory registrations

Pharmgate Animal Health continues to drive performance, biosecurity, and compliance across the animal protein supply chain through science-led solutions and global operational excellence.